Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-22-005990

Director acquired 250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Horne William B. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-04-26 Exercise or conversion : show line 1 in the form +250,000 $0.00 $100 500,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-26 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −250,000 2,000,000 D
Loading xslF345X03/marketforms-56047.xml…